Autopsy report · NCT06536556

Effects of a Single Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: Comparison of Paclitaxel vs Paclitaxel + Trastuzumab vs Paclitaxel + Carboplatine: the PROTECT-06 Bis Study

“Recruitment sufficiant in term of statistical power”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 9 months before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Institut de cancérologie Strasbourg Europe

Sponsor type

University, hospital or other

Conditions

Breast Cancer

Interventions

First Assessment; Second Assessment

Participants

5

Sites

1

Countries

France

Trials that died the same way

• Treatment Regimens for Patients With Resectable Liver Metastases (PANTER Study)
  “Recruitment difficulities” (71% match in meaning)
• Healthy Relationships and Economic Pathways
  “Recruitment too low for power analysis” (66% match in meaning)
• Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer
  “Problems of recruitment” (66% match in meaning)
• Analgesic Effect of Beta 2-mimetics in the Treatment of Neuropathic Pain
  “difficulty of recruitment” (65% match in meaning)
• Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy
  “recruitment problem” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.